GO:1904613 cellular response to 2,3,7,8-tetrachlorodibenzodioxine: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904613 describes how a single cell changes its state or activity in response to 2,3,7,8-tetrachlorodibenzodioxine (TCDD, dioxin), including changes in gene expression, enzyme production, secretion, and movement.
• The aryl hydrocarbon receptor (AhR) is the primary intracellular sensor for TCDD; after ligand binding, AhR moves to the nucleus and drives transcription of target genes such as CYP1A1.
• TCDD exposure triggers oxidative stress, inflammatory signaling, and MAP kinase pathway activation in many cell types.
• Proteomic and transcriptomic studies show that TCDD remodels the cellular proteome and non-coding RNA landscape, including long non-coding RNAs in granulosa cells.
• Cell-type-specific responses occur in keratinocytes, granulosa cells, peripheral blood mononuclear cells, hepatocytes, and microglia.
• CRISPR knockout, knock-in, and overexpression models are essential to test whether candidate genes such as AHR, CYP1A1, or inflammatory mediators are causally involved in TCDD responses.
Description
GO:1904613, cellular response to 2,3,7,8-tetrachlorodibenzodioxine, is a Gene Ontology biological process term that captures any change in a cell's state or activity caused by exposure to TCDD, the most toxic member of the dioxin family. TCDD is a persistent environmental contaminant and a potent activator of the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor that mediates most of its cellular effects. Because TCDD alters gene expression, enzyme production, oxidative status, and inflammatory signaling, the term is central to toxicology, environmental health, and receptor biology research. Researchers use GO:1904613 to annotate and interpret transcriptomic, proteomic, and functional datasets from cells exposed to TCDD, enabling cross-study comparison and mechanistic hypothesis generation. Understanding this process is critical for predicting how dioxin exposure affects human tissues, from skin and reproductive cells to immune and neural cells.
cellular response to 2,3,7,8-tetrachlorodibenzodioxine At A Glance
| GO ID | GO:1904613 |
|---|---|
| GO term | cellular response to 2,3,7,8-tetrachlorodibenzodioxine |
| Ontology | biological_process |
| Synonym | cellular response to dioxin; cellular response to TCDD |
| Major function | Mediates cellular changes in gene expression, enzyme production, secretion, movement, and oxidative status after TCDD exposure |
| Primary sensor | Aryl hydrocarbon receptor (AhR) |
| Key downstream genes | CYP1A1, CYP1B1, AHRR, IL1B, TNF, MAPK pathway components |
| Common cell models | Keratinocytes, granulosa cells, hepatocytes, peripheral blood mononuclear cells, microglia |
| Research methods | RNA-seq, proteomics, CRISPR knockout, qPCR, Western blot, immunofluorescence |
What Is GO:1904613?
In our own words, GO:1904613 refers to any process that results in a change in state or activity of a cell as a result of a 2,3,7,8-tetrachlorodibenzodioxine stimulus. This includes changes in movement, secretion, enzyme production, gene expression, and other cellular activities. The term is synonymous with cellular response to dioxin and cellular response to TCDD, and it is a child of the broader response to TCDD process. It is used when the responding entity is a single cell, not a whole organism or tissue.
Why Is cellular response to 2,3,7,8-tetrachlorodibenzodioxine Important in Cell Biology?
GO:1904613 is important because TCDD is a widespread, persistent environmental toxicant that affects human health through diverse cellular mechanisms. The term provides a standardized way to describe and compare how different cell types respond to TCDD, which is essential for toxicology, risk assessment, and drug discovery. Because AhR is also a therapeutic target in cancer and immune disorders, understanding the cellular response to TCDD helps illuminate both toxic and potentially beneficial AhR signaling pathways.
• TCDD is a potent AhR agonist and a model compound for studying dioxin toxicity.
• The term enables consistent annotation of transcriptomic and proteomic data from TCDD-treated cells.
• TCDD exposure induces oxidative stress and inflammatory responses in multiple cell types.
• AhR signaling is linked to reproductive toxicity, immune modulation, and cancer.
• TCDD affects microglia and neural cells, with implications for neuroinflammation.
• Interindividual variation in CYP1A1 induction highlights genetic susceptibility to TCDD.
• CRISPR models allow causal testing of candidate genes in the TCDD response.
• The term supports cross-species comparisons, from human cells to wildlife hepatocytes.
• Understanding this process aids in developing AhR-targeted therapeutics.
• It connects environmental exposure to molecular and cellular outcomes for regulatory decisions.
What Happens During cellular response to 2,3,7,8-tetrachlorodibenzodioxine?
TCDD binding and AhR activation
In simple terms: TCDD enters the cell and binds to a receptor called AhR, which then changes shape and moves into the nucleus.
TCDD diffuses across the cell membrane and binds with high affinity to the aryl hydrocarbon receptor (AhR) in the cytoplasm. This binding triggers a conformational change that releases AhR from its chaperone complex and exposes a nuclear localization signal. The activated AhR then translocates to the nucleus, where it dimerizes with the aryl hydrocarbon receptor nuclear translocator (ARNT). This AhR-ARNT heterodimer binds to dioxin response elements (DREs) in DNA and initiates transcription of target genes. Knock-down of AhR in porcine granulosa cells alters the lncRNA-mediated response to TCDD, confirming AhR as the central mediator.
Transcriptional reprogramming and enzyme induction
In simple terms: The activated receptor turns on a set of genes, especially those that make detoxifying enzymes.
The AhR-ARNT complex drives expression of phase I and phase II metabolic enzymes, most notably cytochrome P450 family members such as CYP1A1 and CYP1B1. In herring gull embryo hepatocytes, interindividual variation in the CYP1A1 response to TCDD was observed, indicating genetic or epigenetic differences in this transcriptional program. Proteomic analysis of human keratinocytes exposed to TCDD revealed widespread changes in protein abundance, including enzymes involved in oxidative stress and metabolism. Similarly, the proteome of porcine granulosa cells is significantly remodeled by TCDD, affecting proteins related to cell cycle, apoptosis, and steroidogenesis.
Oxidative stress and MAP kinase signaling
In simple terms: TCDD causes the cell to produce harmful oxygen molecules and activates stress signaling pathways.
TCDD exposure increases reactive oxygen species (ROS) and triggers inflammatory responses in various cells. In a study using eicosapentaenoic acid, TCDD-induced oxidative stress and inflammatory response were modulated by MAP kinases and redox-sensitive transcription factors. This indicates that MAPK pathways, including ERK, JNK, and p38, are activated during the cellular response to TCDD and contribute to downstream gene expression changes. These signaling events can lead to apoptosis, cell cycle arrest, or adaptation depending on the cell type and dose.
Non-coding RNA and epigenetic regulation
In simple terms: TCDD also changes the levels of regulatory RNAs that control gene expression.
In porcine granulosa cells, TCDD alters the expression of long non-coding RNAs (lncRNAs), and AhR knock-down affects this lncRNA-mediated response. This suggests that non-coding RNAs participate in the cellular response to TCDD, potentially fine-tuning the transcriptional output. Additionally, TCDD can induce epigenetic changes, although these are not fully characterized in all cell types. The involvement of lncRNAs adds a layer of complexity to GO:1904613, extending beyond protein-coding gene regulation.
Cell-type-specific outcomes
In simple terms: Different cells respond to TCDD in different ways, such as immune cells becoming activated or brain cells becoming primed for injury.
The cellular response to TCDD is highly context-dependent. In peripheral blood mononuclear cells from women with endometriosis, TCDD exposure modulates immune responses, suggesting a role in inflammatory pathologies. In cortical microglia, gestational and lactational TCDD exposure primes cells to tissue injury, indicating long-lasting effects on neuroimmune function. Human keratinocytes respond to TCDD with proteomic changes related to differentiation and stress. These examples illustrate that GO:1904613 encompasses diverse cell-type-specific outcomes, all initiated by TCDD-AhR signaling.
Key Genes Involved in GO:1904613 cellular response to 2,3,7,8-tetrachlorodibenzodioxine
The following genes and proteins are central to the cellular response to TCDD, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AHR | Primary receptor for TCDD; mediates transcriptional responses | Knock-down or knockout abolishes TCDD-induced lncRNA and gene expression changes |
| ARNT | Dimerization partner of AhR; required for DNA binding | Essential for AhR signaling; target for functional studies |
| CYP1A1 | Phase I enzyme induced by TCDD; metabolizes xenobiotics | Biomarker of TCDD exposure; interindividual variation studied |
| CYP1B1 | Phase I enzyme induced by TCDD | Involved in oxidative stress and carcinogen activation |
| AHRR | AhR repressor; feedback inhibitor of AhR signaling | Regulates duration of TCDD response |
| MAPK1 (ERK2) | Kinase in MAPK pathway activated by TCDD | Modulates oxidative stress and inflammatory response |
| MAPK3 (ERK1) | Kinase in MAPK pathway activated by TCDD | Contributes to TCDD-induced signaling |
| MAPK8 (JNK1) | Stress-activated kinase | Involved in TCDD-induced apoptosis and inflammation |
| MAPK14 (p38) | Stress-activated kinase | Mediates TCDD-induced oxidative stress responses |
| NFE2L2 (NRF2) | Redox-sensitive transcription factor | Modulates TCDD-induced oxidative stress |
| NFKB1 | Inflammatory transcription factor | Activated by TCDD; drives cytokine expression |
| IL1B | Pro-inflammatory cytokine | Induced by TCDD in immune cells |
| TNF | Pro-inflammatory cytokine | Upregulated in TCDD-treated cells |
| CYP1A2 | Phase I enzyme | Induced by TCDD in liver cells |
| UGT1A1 | Phase II enzyme | May be induced by TCDD via AhR |
| NQO1 | Antioxidant enzyme | Part of NRF2-mediated response to TCDD |
| HMOX1 | Heme oxygenase 1; antioxidant | Induced by TCDD-induced oxidative stress |
How Is cellular response to 2,3,7,8-tetrachlorodibenzodioxine Regulated?
The cellular response to TCDD is tightly regulated at multiple levels. The AhR signaling pathway is controlled by feedback mechanisms, including induction of AHRR (AhR repressor), which competes with AhR for ARNT binding and inhibits DRE-driven transcription. Additionally, MAP kinase pathways modulate the intensity and duration of the response; inhibition of MAP kinases alters TCDD-induced oxidative stress and inflammatory gene expression. Redox-sensitive transcription factors such as NRF2 and NF-kB further regulate the cellular outcome, balancing antioxidant defense and inflammation. Non-coding RNAs, including lncRNAs, add another layer of regulation, as demonstrated in porcine granulosa cells where AhR knock-down altered lncRNA expression. Interindividual genetic variation also affects the magnitude of CYP1A1 induction, as seen in herring gull hepatocytes.
cellular response to 2,3,7,8-tetrachlorodibenzodioxine and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AHR | Endometriosis, cancer, neuroinflammation | AhR knockout or knock-down in granulosa cells, microglia, or PBMCs |
| CYP1A1 | TCDD exposure biomarker, cancer susceptibility | CYP1A1 knockout or overexpression in hepatocytes or keratinocytes |
| IL1B | Inflammatory diseases, endometriosis | IL1B knockout in PBMCs treated with TCDD |
| MAPK14 (p38) | Oxidative stress, inflammation | p38 knockout or point mutation in keratinocytes or granulosa cells |
| NFE2L2 (NRF2) | Antioxidant response, cancer | NRF2 knockout in TCDD-treated cells |
TCDD and endometriosis
TCDD exposure has been linked to endometriosis, a chronic inflammatory gynecological disease. In peripheral blood mononuclear cells from women with endometriosis, TCDD modulates immune responses, potentially exacerbating inflammation. The cellular response to TCDD in these cells may contribute to disease pathogenesis by altering cytokine production and immune cell activity. Understanding GO:1904613 in the context of endometriosis could reveal new therapeutic targets.
TCDD and neuroinflammation
Gestational and lactational exposure to TCDD primes cortical microglia to tissue injury, suggesting that early-life dioxin exposure can have long-lasting effects on neuroimmune function. This priming may increase susceptibility to neurodegenerative or neuroinflammatory conditions later in life. The cellular response to TCDD in microglia involves changes in gene expression that sensitize these cells to subsequent insults. This highlights the importance of GO:1904613 in developmental neurotoxicology.
TCDD and cancer
TCDD is classified as a human carcinogen, and its cellular effects include induction of cytochrome P450 enzymes that can activate procarcinogens, as well as promotion of oxidative stress and inflammation. AhR signaling is also implicated in cancer cell proliferation and survival. The cellular response to TCDD may therefore contribute to tumor initiation and progression in exposed tissues. Studying GO:1904613 helps clarify the molecular mechanisms linking dioxin exposure to cancer risk.
TCDD and reproductive toxicity
TCDD exposure impairs ovarian function and steroidogenesis. In porcine granulosa cells, TCDD alters the proteome and lncRNA landscape, affecting proteins involved in cell cycle and apoptosis. These changes can disrupt follicle development and ovulation, contributing to reproductive toxicity. The cellular response to TCDD in granulosa cells is therefore a key area for understanding dioxin-induced infertility.
From cellular response to 2,3,7,8-tetrachlorodibenzodioxine-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does AhR mediate TCDD-induced lncRNA changes? | AhR knockout or knock-down in porcine granulosa cells (AVG-16) |
| What proteins change after TCDD exposure? | Proteomics in human keratinocytes or porcine granulosa cells |
| Does CYP1A1 induction vary genetically? | CRISPR knock-in of variant alleles in hepatocyte cell lines |
| Does p38 MAPK drive TCDD-induced inflammation? | p38 knockout or point mutation in immune cells |
| Does TCDD prime microglia for injury? | Microglia-specific AhR knockout in mice |
| Can overexpression of AHRR suppress TCDD response? | AHRR overexpression in TCDD-treated cells |
How to Study the cellular response to 2,3,7,8-tetrachlorodibenzodioxine Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes | Identify TCDD-induced genes and lncRNAs |
| Proteomics | Protein abundance and modifications | Discover TCDD-responsive proteins in keratinocytes or granulosa cells |
| CRISPR knockout | Loss-of-function effects | Test requirement of AhR, CYP1A1, or MAPKs in TCDD response |
| qPCR | Expression of specific genes | Quantify CYP1A1 induction as a TCDD biomarker |
| Western blot | Protein levels and phosphorylation | Measure AhR, CYP1A1, or MAPK activation |
| Immunofluorescence | Subcellular localization | Visualize AhR nuclear translocation |
| CRISPR knock-in | Variant allele function | Study interindividual differences in CYP1A1 induction |
| CRISPR library screening | Genome-wide regulators | Identify novel genes controlling TCDD response |
Transcriptomics and RNA-seq
RNA sequencing is widely used to profile global gene expression changes after TCDD exposure, revealing AhR target genes and non-coding RNAs. In porcine granulosa cells, RNA-seq identified lncRNAs whose expression was altered by TCDD and dependent on AhR. This method provides a comprehensive view of the transcriptional reprogramming that defines GO:1904613.
Proteomics
Mass spectrometry-based proteomics measures changes in protein abundance and post-translational modifications after TCDD treatment. In human keratinocytes, proteomic analysis revealed alterations in proteins involved in oxidative stress, metabolism, and differentiation. Similarly, the proteome of porcine granulosa cells was significantly remodeled by TCDD, identifying potential biomarkers and mechanistic insights.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression models allow causal testing of candidate genes in the TCDD response. For example, AhR knock-down in granulosa cells demonstrated its requirement for TCDD-induced lncRNA changes. CRISPR screens can identify novel regulators of GO:1904613 across the genome, accelerating discovery of therapeutic targets.
Imaging and immunoassays
Immunofluorescence and Western blotting are used to visualize AhR nuclear translocation, CYP1A1 induction, and activation of MAP kinases after TCDD exposure. These methods provide spatial and temporal information about the cellular response. They are often combined with qPCR to quantify target gene expression.
How CRISPR Can Be Used to Study GO:1904613 cellular response to 2,3,7,8-tetrachlorodibenzodioxine
Knockout
CRISPR knockout of AHR or ARNT completely abolishes TCDD-induced gene expression, confirming their essential roles in GO:1904613. Knockout of downstream effectors such as CYP1A1 or MAPK14 can reveal their specific contributions to oxidative stress and inflammation. These models are invaluable for dissecting the causal hierarchy of the TCDD response.
Point Mutation
Point mutations can be introduced into the ligand-binding domain of AHR to test residues critical for TCDD binding, or into CYP1A1 to alter enzyme activity. Such models help distinguish between receptor-mediated and metabolic effects of TCDD. They also allow study of naturally occurring human polymorphisms that affect TCDD sensitivity.
Knock-in
Knock-in of tagged AHR (e.g., GFP-AhR) enables live-cell imaging of receptor trafficking and nuclear translocation after TCDD exposure. Knock-in of DRE-driven reporter genes allows quantitative measurement of AhR transcriptional activity. These models are powerful for high-content screening of AhR modulators.
Overexpression
Overexpression of AHRR or other negative regulators can suppress the cellular response to TCDD, providing insight into feedback control. Conversely, overexpression of CYP1A1 may enhance TCDD-induced oxidative stress. Overexpression models are useful for gain-of-function studies and for validating therapeutic targets.
How EDITGENE Supports cellular response to 2,3,7,8-tetrachlorodibenzodioxine Research
Researchers studying cellular response to 2,3,7,8-tetrachlorodibenzodioxine-related genes often need to determine whether a candidate gene is causally involved in the response or merely correlated with it. EDITGENE provides the CRISPR tools and services to establish causality through precise genome editing, from knockout to knock-in and overexpression.
Contact EDITGENE today to design your custom CRISPR model for cellular response to 2,3,7,8-tetrachlorodibenzodioxine research.
Frequently Asked Questions About cellular response to 2,3,7,8-tetrachlorodibenzodioxine
What is GO:1904613?
GO:1904613 is the Gene Ontology term for cellular response to 2,3,7,8-tetrachlorodibenzodioxine, describing any change in a cell's state or activity caused by TCDD exposure.
What genes are involved in cellular response to TCDD?
Key genes include AHR, ARNT, CYP1A1, CYP1B1, AHRR, MAPK1, MAPK3, MAPK8, MAPK14, NFE2L2, NFKB1, IL1B, and TNF.
How does TCDD activate cells?
TCDD binds to the aryl hydrocarbon receptor (AhR), which then moves to the nucleus, pairs with ARNT, and turns on target genes like CYP1A1.
What cell types respond to TCDD?
Many cell types respond, including keratinocytes, granulosa cells, hepatocytes, peripheral blood mononuclear cells, and microglia.
What diseases are linked to TCDD exposure?
TCDD exposure is linked to endometriosis, neuroinflammation, cancer, and reproductive toxicity.
How can I study GO:1904613 in the lab?
Common methods include RNA-seq, proteomics, qPCR, Western blot, and CRISPR knockout or knock-in models.
What is the role of AhR in TCDD response?
AhR is the primary receptor for TCDD; its activation mediates most transcriptional and cellular changes.
Does TCDD cause oxidative stress?
Yes, TCDD induces reactive oxygen species and inflammatory responses, often through MAP kinase and redox-sensitive transcription factors.
Can CRISPR help study TCDD effects?
Yes, CRISPR knockout of AHR or other genes can confirm their causal role in the cellular response to TCDD.
What is the difference between GO:1904613 and response to TCDD?
GO:1904613 specifically refers to the response of a single cell, while broader terms may cover tissue or organism-level responses.
Conclusion
GO:1904613, cellular response to 2,3,7,8-tetrachlorodibenzodioxine, is a critical Gene Ontology term for understanding how cells react to the environmental toxicant TCDD. The response is mediated primarily by the AhR pathway and involves widespread changes in gene expression, enzyme induction, oxidative stress, and inflammation. Cell-type-specific outcomes range from immune modulation to neuroinflammation and reproductive toxicity. Researchers can leverage CRISPR-based models to dissect the causal roles of individual genes and accelerate the development of interventions for dioxin-related diseases.
References
- 1. Palanisamy K et al.. 2015. Eicosapentaenoic acid prevents TCDD-induced oxidative stress and inflammatory response by modulating MAP kinases and redox-sensitive transcription factors.. Br J Pharmacol 172(19):4726-40 PMID: 26177858
- 2. Swigonska S et al.. 2023. Knock-down of aryl hydrocarbon receptor (AhR) affects the lncRNA-mediated response of porcine granulosa cells (AVG-16 cell line) to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).. Anim Reprod Sci 255:107277 PMID: 37315452
- 3. Safe S et al.. 1991. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanism of action.. Pharmacol Toxicol 69(6):400-9 PMID: 1766914
- 4. Hu Q et al.. 2013. Proteomic analysis of human keratinocyte response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure.. J Proteome Res 12(11):5340-7 PMID: 23991859
- 5. Orlowska K et al.. 2018. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the proteome of porcine granulosa cells.. Chemosphere 212:170-181 PMID: 30144678
- 6. Tanha M et al.. 2022. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin potential impacts on peripheral blood mononuclear cells of endometriosis women.. J Reprod Immunol 149:103439 PMID: 34781065
- 7. Lowery RL et al.. 2022. Gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin primes cortical microglia to tissue injury.. Brain Behav Immun 101:288-303 PMID: 35065196
- 8. Head JA et al.. 2019. Interindividual variation in the cytochrome P4501A response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in herring gull embryo hepatocytes.. Environ Toxicol Chem 38(3):660-670 PMID: 30615215
